Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00055562
What this trial is testing

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
Celgene Corporation 274
Testing effectiveness (Phase 2)Study completedNCT00533702
What this trial is testing

IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Eli Lilly and Company 106
Early research (Phase 1)Looking for participantsNCT05092373
What this trial is testing

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Who this might be right for
Advanced Breast CarcinomaAdvanced Endometrial CarcinomaAdvanced Fallopian Tube Carcinoma+71 more
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT00304200
What this trial is testing

Temodar and Sutent as Therapy for Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Northern California Melanoma Center 7
Early research (Phase 1)Study completedNCT03619681
What this trial is testing

Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer

Who this might be right for
Breast CancerGastric Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 63
Not applicableActive Not RecruitingNCT04030507
What this trial is testing

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer+3 more
Brigham and Women's Hospital 214
Testing effectiveness (Phase 2)UnknownNCT02452294
What this trial is testing

Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)

Who this might be right for
Malignant MelanomaMetastases
University Hospital Tuebingen 22
Not applicableStudy completedNCT00709631
What this trial is testing

Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers

Who this might be right for
Chronic Leg Ulcers
Assistance Publique - Hôpitaux de Paris 155
Testing effectiveness (Phase 2)UnknownNCT03910712
What this trial is testing

Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC

Who this might be right for
Breast Cancer FemaleHER2-positive Breast CancerHormone Receptor Positive Malignant Neoplasm of Breast+3 more
Peking Union Medical College Hospital 250
Not applicableStudy completedNCT05576545
What this trial is testing

Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment

Who this might be right for
Breast CancerBreast NeoplasmBreast Malignant Tumor+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 73
Testing effectiveness (Phase 2)Looking for participantsNCT06209580
What this trial is testing

AMT-253 in Patients With Advanced Solid Tumours

Who this might be right for
Malignant MelanomaAdvanced Solid Tumors
Multitude Therapeutics Inc. 96
Testing effectiveness (Phase 2)Ended earlyNCT00068666
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Alliance for Clinical Trials in Oncology 41
Not applicableLooking for participantsNCT05539677
What this trial is testing

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Who this might be right for
Malignant Solid TumorsPrimary Brain TumorMelanoma+4 more
N.N. Petrov National Medical Research Center of Oncology 1,000
Early research (Phase 1)Not Yet RecruitingNCT07694414
What this trial is testing

Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events

Who this might be right for
Immune-Related Adverse Events
Inge Marie Svane 25
Large-scale testing (Phase 3)Study completedNCT00175643
What this trial is testing

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Who this might be right for
Actinic Keratoses
University of British Columbia 20
Early research (Phase 1)Study completedNCT03084640
What this trial is testing

Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Regeneron Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT01278940
What this trial is testing

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Oslo University Hospital 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494
What this trial is testing

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)UnknownNCT05094804
What this trial is testing

OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+7 more
OncoResponse, Inc. 172
Next Page